GGI
REGN icon

Godsey & Gibb Inc’s Regeneron Pharmaceuticals REGN Stock Holding History

Godsey & Gibb Inc’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.27K Buy
+3
New +$2.27K ﹤0.01% 372
2024
Q4 		– Sell
-130
Closed -$137K – 421
2024
Q3 		$137K Hold
130
– – 0.01% 130
2024
Q2 		$137K Hold
130
– – 0.01% 133
2024
Q1 		$125K Hold
130
– – 0.01% 123
2023
Q4 		$114K Hold
130
– – 0.01% 123
2023
Q3 		$107K Hold
130
– – 0.01% 129
2023
Q2 		$93.4K Hold
130
– – 0.01% 137
2023
Q1 		$107K Hold
130
– – 0.01% 131
2022
Q4 		$93.8K Hold
130
– – 0.02% 90
2022
Q3 		$90K Buy
+130
New +$81.8K 0.07% 24

Other funds holding REGN

GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
WC
Woodstock Corp Boston, Massachusetts $1.24B AUM 22.02% 1-Year Est. Return
SBWIC
Schaper Benz & Wise Investment Counsel Neenah, Wisconsin $1.51B AUM 27.44% 1-Year Est. Return
NPPM
North Point Portfolio Managers Orange Village, Ohio $595M AUM 14.89% 1-Year Est. Return

Godsey & Gibb Inc's REGN Position: Q3 2026 in Review

Godsey & Gibb Inc opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 3 shares worth $2.27K. The stake represents ﹤0.01% of the portfolio and ranks #372 among its holdings. This is a return to the name: Godsey & Gibb Inc previously reported a position in REGN as recently as Q3 2024.

Godsey & Gibb Inc first reported a position in REGN in Q3 2022 and has held it in 10 quarters since. The position peaked at $137K in Q3 2024. 120 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Godsey & Gibb Inc held 3 shares of Regeneron Pharmaceuticals worth $2.27K as of Q3 2026.
  • Regeneron Pharmaceuticals was a new Godsey & Gibb Inc position in Q3 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Godsey & Gibb Inc's portfolio in Q3 2026, its #372 holding.
  • Godsey & Gibb Inc first reported a position in Regeneron Pharmaceuticals in Q3 2022 and has held it in 10 quarters since.
  • Godsey & Gibb Inc's Regeneron Pharmaceuticals position peaked at $137K in Q3 2024.
  • 120 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Godsey & Gibb Inc's 13F filing for Q3 2026, filed 14 Oct 2026.